---
title: "H.C. Wainwright Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265997094.md"
description: "H.C. Wainwright analyst Douglas Tsao reaffirmed a Buy rating for Protagonist Therapeutics with a price target of $80.00. Tsao, who covers the Healthcare sector, has an average return of 22.0% and a 53.85% success rate. Citi's Geoff Meacham also issued a Buy rating, while TR | OpenAI reiterated a Hold rating on Protagonist Therapeutics."
datetime: "2025-11-14T23:38:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265997094.md)
  - [en](https://longbridge.com/en/news/265997094.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265997094.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265997094.md) | [繁體中文](https://longbridge.com/zh-HK/news/265997094.md)


# H.C. Wainwright Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX)

H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Protagonist Therapeutics today and set a price target of $80.00.

### Meet Your ETF AI Analyst

-   Discover how TipRanks' _ETF_ AI Analyst can help you make smarter investment decisions
-   Explore ETFs TipRanks' users love and see what insights the **_ETF_ AI Analyst** reveals about the ones you follow.

Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Hansa Biopharma AB, and Alkermes. According to TipRanks, Tsao has an average return of 22.0% and a 53.85% success rate on recommended stocks.

In addition to H.C. Wainwright, Protagonist Therapeutics also received a Buy from Citi’s Geoff Meacham in a report issued on November 10. However, on November 11, TR | OpenAI – 4o reiterated a Hold rating on Protagonist Therapeutics (NASDAQ: PTGX).

### Related Stocks

- [Protagonist Therapeutics, Inc. (PTGX.US)](https://longbridge.com/en/quote/PTGX.US.md)

## Related News & Research

- [OpenAI: Building a unified AI superapp…](https://longbridge.com/en/news/281237517.md)
- [OpenAI Launches Bug Bounty Program To Cripple AI Weaponization](https://longbridge.com/en/news/280830008.md)
- [Meet 'Dobby': The AI agent that could kill the app economy](https://longbridge.com/en/news/281354277.md)
- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/en/news/281311983.md)
- [SharonAI Secures Major Long-Term AI Cloud Services Deal](https://longbridge.com/en/news/281363534.md)